Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NASDAQ Clean Edge Green Energy UCITS ETF 26.03.2026 QCLN.LN IE00BDBRT036 975,002.00 USD 17,143,751.11 17.583  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Innovative Transaction & Process UCITS ETF 26.03.2026 LEGR LN IE00BF5DXP42 1,000,002.00 USD 46,955,483.86 46.955  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 26.03.2026 LANDXN.LN IE000RN036E0 34,035.00 USD 677,780.19 19.914  ...

PECHINO--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), un'azienda biotecnologica globale che promuove la ricerca e lo sviluppo di nuovi farmaci a base di anticorpi con tecnologie innovative, oggi ha annunciato che la sua azienda partner NEOK Bio, Inc. ha recentemente ottenuto l'approvazione da parte della statunitense Food and Drug Administration (FDA) della domanda per un nuovo farmaco sperimentale (IND) relativa a NEOK002, un programma...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 26.03.2026 LANDXEN.LN IE000C75IMX8 15,878.00 USD 288,465.12 18.168  ...

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Equitable Holdings, Inc. (NYSE: EQH) and Corebridge Financial, Inc. (NYSE: CRBG). Under the terms of the agreement, each outstanding share of Equitable common stock will be exchanged for the right to receive 1.55516 shares of the new parent company’s common stock, and upon completion of the proposed transact...

PÉKIN--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), une entreprise mondiale de biotechnologie qui se consacre à la recherche et au développement de nouveaux médicaments à base d’anticorps en utilisant des technologies innovantes, a annoncé aujourd’hui que son partenaire NEOK Bio, Inc. a obtenu l’autorisation de la Food and Drug Administration (FDA) des États-Unis pour une demande d’investigation de nouveau médicament (IND) pour NEOK002,...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Smart Grid Infrastructure UCITS ETF 26.03.2026 GRDU.LN IE000J80JTL1 28,150,002.00 USD 1,579,901,771.70 56.124  ...

PHOENIX--(BUSINESS WIRE)--VIVAZEN®, the nation’s leading botanical wellness company, welcomed congressional scrutiny of 7-hydroxymitragynine (7-OH) as the House Energy and Commerce Subcommittee on Health holds a legislative hearing on H.R. 8000, the End Needless Distribution of 7-OH Act, introduced by Representative Gus Bilirakis (R-FL) and related illicit-drug legislation. The hearing underscores growing concern in Washington about 7-OH, as members of the subcommittee called on the Drug Enforc...

BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), ein globales Biotechnologieunternehmen, das die Forschung und Entwicklung neuartiger antikörperbasierter Medikamente mit innovativen Technologien vorantreibt, gab heute bekannt, dass sein Partner NEOK Bio, Inc. kürzlich von der US-amerikanischen Food and Drug Administration (FDA) die Zulassung für einen Antrag auf ein neues Prüfpräparat (IND) für NEOK002 erhalten hat, ein ADC-Program...